Brickell Historical Balance Sheet


USD 3.36  0.09  2.75%   

Trend analysis of Brickell Biotech balance sheet accounts such as Total Assets of 37.2 M, Current Assets of 35 M or Assets Non Current of 120.1 K provides information on Brickell Biotech's total assets, liabilities, and equity, which is the actual value of Brickell Biotech to its prevalent stockholders. By breaking down trends over time using Brickell Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Brickell Biotech prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brickell Biotech is a good buy for the upcoming year.
Continue to Trending Equities.

About Brickell Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Brickell Biotech at a specified time, usually calculated after every quarter, six months, or one year. Brickell Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Brickell Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Brickell currently owns. An asset can also be divided into two categories, current and non-current.

Brickell Biotech Balance Sheet Chart

Brickell Biotech Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Brickell Biotech uses and utilizes its capital. It also shows what exactly a company owns and owes.
Brickell Biotech Current Assets are most likely to decrease significantly in the upcoming years. The last year's value of Current Assets was reported at 29.6 Million. The current Assets Non Current is estimated to increase to about 120.1 K, while Accumulated Other Comprehensive Income is projected to decrease to (25.9 K).

Total Assets

Total assets refers to the total amount of Brickell Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Brickell Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Current Assets

Current assets of Brickell Biotech include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Brickell Biotech. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Brickell Biotech balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Brickell Biotech books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Brickell Biotech balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Brickell Biotech Current Assets are most likely to decrease significantly in the upcoming years. The last year's value of Current Assets was reported at 29.6 Million. The current Assets Non Current is estimated to increase to about 120.1 K, while Accumulated Other Comprehensive Income is projected to decrease to (25.9 K).
 2019 2020 2021 2022 (projected)
Current Assets17.97 M33.53 M29.6 M34.99 M
Total Assets18.14 M33.63 M29.72 M37.17 M

Brickell Biotech balance sheet Correlations

Click cells to compare fundamentals

Brickell Biotech Account Relationship Matchups

Brickell Biotech balance sheet Accounts

201720182019202020212022 (projected)
Accounts Payable326 K1.21 M412 K2.25 M2.02 M2.18 M
Accumulated Other Comprehensive Income40 K25 K122 K(28 K)(25.2 K)(25.86 K)
Total Assets80.49 M8.75 M18.14 M33.63 M29.72 M37.17 M
Current Assets76.32 M8.27 M17.97 M33.53 M29.6 M34.99 M
Assets Non Current4.18 M478 K175 K104 K117 K120.08 K
Cash and Equivalents25.03 M8.07 M7.23 M30.11 M26.88 M24.71 M
Cash and Equivalents USD25.03 M8.07 M7.23 M30.11 M26.88 M24.71 M
Deferred Revenue3.02 M11.7 M9.71 M1.79 M2.06 M3.03 M
Shareholders Equity63.58 M(71.62 M)7.57 M27.14 M24.91 M28.61 M
Shareholders Equity USD63.58 M(71.62 M)7.57 M27.14 M24.91 M28.61 M
Goodwill and Intangible Assets1.3 M810 K703 K441 K396.9 K407.35 K
Investments25.31 M32.6 M37.87 M4.5 M4.05 M4.15 M
Investments Current23.26 M30.55 M35.66 M4.5 M5.17 M5.31 M
Total Liabilities16.92 M22.08 M10.57 M6.5 M4.81 M4.94 M
Current Liabilities16.92 M20.09 M10.5 M6.35 M4.81 M7.32 M
Trade and Non Trade Payables5.22 M4.07 M2.25 M568 K1.6 M2.47 M
Property Plant and Equipment Net606 K37 K175 K104 K117 K120.08 K
Accumulated Retained Earnings Deficit(426.74 M)(71.62 M)(84.98 M)(105.89 M)(145.37 M)(156.84 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Brickell Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamentals Comparison Now


Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving together with Brickell Biotech

0.82ALRNAileron Therapeutics Earnings Call  TomorrowPairCorr

Moving against Brickell Biotech

0.91AGLAgilon Health Downward RallyPairCorr
0.79ARWRArrowhead Pharma Fiscal Year End 28th of November 2022 PairCorr
0.6ALXOAlx Oncology Holdings Aggressive PushPairCorr
0.53ATAIAtai Life Sciences Earnings Call  TomorrowPairCorr
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.9 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.